XBiotech Inc. - Common Stock (XBIT)

XBiotech just reported results for the second quarter of 2024.

XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, highlighting the safety and tolerability of Natrunix with the ONIVYDE + 5-Fluorouracil + Leucovorin regimen.

XBiotech just reported results for the first quarter of 2024.

XBiotech just reported results for the fourth quarter of 2023.

  Thursday saw 177 companies set new 52-week lows.

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Gainers

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.37% to 33,135.37 while the NASDAQ rose 0.39% to 12,391.68. The S&P 500, also rose, gaining, 0.45% to 4,128.33.

  On Monday, 195 stocks hit new 52-week lows.

  On Monday, 79 companies reached new 52-week lows.

  On Thursday, 550 companies achieved new lows for the year.

  On Thursday, 1076 companies hit new 52-week lows.

Here's a roundup of top developments in the biotech space over the last 24 hours:

  On Tuesday, 507 stocks hit new 52-week lows.

  On Monday, 198 companies reached new 52-week lows.

  On Monday, 429 stocks made new 52-week lows.

  On Wednesday, 238 companies achieved new lows for the year.

 

  On Monday, 92 companies set new 52-week lows.

  During the Thursday's session, 100 stocks hit new 52-week lows.

  On Tuesday, 540 companies set new 52-week lows.

Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric...